Belite Bio BLTE
NASDAQ BLTE
$162.98 -6.84 (-4.03%)
At close: Oct 1, 2026 · 4:00 PM EDT

Belite Bio (BLTE) Depreciation & Amortization (CF) (2024 - 2025)

Updated

Belite Bio's Depreciation & Amortization (CF) came in at $45,000 for Q4 2025, up 4.7% from $43,000 a year earlier.

Analysis

Belite Bio (BLTE) Depreciation & Amortization (CF) (2024 - 2025) Analysis & Trends

For FY2025, Belite Bio's Depreciation & Amortization (CF) was $464,000, up 3.3% from FY2024.

  • Depreciation & Amortization (CF) has increased in each of the last five years, with a five-year compound annual growth rate of 93.7% (FY2020 to FY2025).
  • Going back by year, Depreciation & Amortization (CF) was $449,000 in FY2024 (+12.5%), $399,000 in FY2023 (+101.5%), $198,000 in FY2022 (+560.0%) and $30,000 in FY2021 (+76.5%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Belite Bio 6.68 Bn 6.68 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 45,000.00
Dec 31, 2024 43,000.00
API Access

Belite Bio Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=BLTE&period=max&api_key=YOUR_API_KEY